menu
    • menu

    Company profile for Mangoceuticals

    NEW Drugs in Dev: 5
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MangoRx is a new men’s health and wellness company dedicated to developing, marketing, and selling a variety of men’s wellness products and services via a telemedicine platform that connects consumers to licensed healthcare professionals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MangoceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    15110 N. Dallas Pkwy., Suite 600, Dallas, Texas 75248
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mangorx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mangorx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/mango_rx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    India Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    India Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mangoceuticals Sues Clarity Ventures For Over $73M Damages
    Mangoceuticals Sues Clarity Ventures For Over $73M Damages

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257629/0/en/Mangoceuticals-Announces-Lawsuit-Seeking-Damages-Exceeding-73-Million-Against-Former-Technology-Consulting-and-Software-Development-Firm-Clarity-Ventures-Inc.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Mangoceuticals Files PCT Patent For MGX-0024 Antiviral Tech
    Mangoceuticals Files PCT Patent For MGX-0024 Antiviral Tech

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3251266/0/en/Mangoceuticals-Inc-Announces-PCT-Patent-Filing-for-MGX-0024-Antiviral-Technology-to-Include-Inhibiting-Respiratory-or-Orally-Acquired-Virus-Infection-in-Animals-or-Birds.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    Mango Pharma's MGX-0024 Achieves Zero Mortality in H5N1 Trials
    Mango Pharma's MGX-0024 Achieves Zero Mortality in H5N1 Trials

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3243022/0/en/Mangoceuticals-Patented-MGX-0024-Achieves-Zero-Respiratory-Related-Mortality-in-29-000-Bird-Field-Trials-and-Demonstrates-Prophylactic-Benefit-Against-H5N1-in-Controlled-Government.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Mangoceuticals, Cube Group Ink $100M Solana DAT Deal
    Mangoceuticals, Cube Group Ink $100M Solana DAT Deal

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208432/0/en/Mangoceuticals-Inc-Announces-Partnership-with-The-Cube-Group-to-Launch-Up-To-100-Million-Solana-Focused-Digital-Asset-Treasury-DAT-Strategy.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Mangoceuticals Closes $2.5M Registered Direct/Private Placements
    Mangoceuticals Closes $2.5M Registered Direct/Private Placements

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208609/0/en/Mangoceuticals-Inc-Announces-Closing-of-2-5-Million-Registered-Direct-and-Private-Placements.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Mangoceuticals Secures $2.5M Nasdaq Placement
    Mangoceuticals Secures $2.5M Nasdaq Placement

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207712/0/en/Mangoceuticals-Inc-Announces-2-5-Million-Registered-Direct-and-Private-Placements-Priced-at-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search